Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
Part of Washington Convention Center to become field hospital for COVID-19 patients
01:01pm, Monday, 20'th Apr 2020
Parts of the Walter E. Washington Convention Center will be converted into a field hospital.
The Race Continues for a COVID-19 Vaccine; 3 Healthcare Stocks to Watch
12:58pm, Monday, 13'th Apr 2020
The question keeping the world up at night: when will a COVID-19 vaccine be ready? Since China released the virus’ genetic sequence on January 10, researchers in several countries have been working
The Race Continues for a COVID-19 Vaccine; 3 Healthcare Stocks to Watch
12:56pm, Monday, 13'th Apr 2020
The question keeping the world up at night: when will a COVID-19 vaccine be ready? Since China released the virus’ genetic sequence on January 10,
D.C., Md., Va. facing budget issues with declines in tax revenue, big coronavirus expenses
12:18pm, Wednesday, 08'th Apr 2020
Maryland Gov. Larry Hogan says his state has already spent close to $2 billion on the coronavirus crisis.
My Top 4 COVID-19 Tickers For Consideration
05:52pm, Monday, 06'th Apr 2020
The market is searching for healthcare stocks that could be a major player in the Coronavirus Crisis. My speculative portfolio is loaded with some of these COVI
Exclusive: Rockville bio raising $50M, building COVID-19 vaccine — and plotting IPO
06:51pm, Thursday, 02'nd Apr 2020
Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville.
Two coronavirus vaccine candidates are in the clinics and 42 more are in preclinical studies, according to updated data provided by the World Health Organization on March 20.Three biopharma companies
Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine
11:00am, Monday, 30'th Mar 2020
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced that it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its sin
‘Breaking into two spheres!’ MoD insider warns coronavirus threatening new Cold War
07:45am, Monday, 30'th Mar 2020
CORONAVIRUS could be the start of a new Cold War scenario, as the US and China continue to point the finger at each other, former Ministry of Defence Minister Tobias Ellwood has warned Express.co.uk.
Afternoon Market Stats in 5 Minutes
05:18pm, Friday, 27'th Mar 2020
Movers Indices • S&P 500 ETF (NYSE:SPY) decreased 2.46% to $254.50.• Nasdaq ETF (NASDAQ:QQQ) fell 2.65% to $186.81.• Dow Jones Industrial Average ETF (NYSE:DIA) decreased 3.05% to $217.97.• FT
Fly Intel: Pre-market Movers WW;SCWX;GME;KBH;ALT;OCGN;QFIN;LULU;TXMD;HTZ;GPS
01:26pm, Friday, 27'th Mar 2020
Fly Intel: Pre-market Movers WW SCWX GME KBH ALT OCGN QFIN LULU TXMD HTZ GPS
CCL, RBS among premarket losers
01:22pm, Friday, 27'th Mar 2020
Arlington Asset Investment (NYSE:AI) -21% after suspending Q1 dividend.BGC Partners (NASDAQ:BGCP) -20% on dividend cut.Altimmune (NASDAQ:ALT) -15% on FY earnings.Arbutus Biopharma (NASDAQ:ABUS)�
The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance
12:02pm, Friday, 27'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.None of the NYSE- or Nasdaq-listed biotech stocks hit 52 week highs Thursday.Down In The Dumps (Biotech Stocks Hitting
Altimmune Announces Financial Results for the Year Ended December 31, 2019 and Provides a Corporate Update
11:15am, Friday, 27'th Mar 2020
GAITHERSBURG, Md., March 27, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the year ended December.
Altimmune Inc to Host Earnings Call
10:30am, Friday, 27'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Altimmune Inc (NASDAQ:ALT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 27, 2020 at 8:30 AM Eas
